ArticleJournal of biophotonics2026
Comparing the Effects of Chemical Optical Clearing Agents and Mechanical Compression on the Optical Attenuation of Porcine Skin.
Article in Journal of biophotonics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Light scattering remains a primary challenge for deep-tissue optical diagnostics and therapies. While Optical Clearing Agents (OCAs) are used to reduce skin attenuation, Mechanical Compression (MC) is also applied in clinical settings despite its inconclusive results. Their relative effectiveness under standardized conditions remains poorly characterized. This study quantitatively compares various OCA formulations, including mineral oil, PEG-400, fructose, and tartrazine, with enhancers such as oleic acid and 1,2-propanediol, under load-dependent MC (1.6-47 kPa). Using spectral-domain OCT at 840 nm on porcine skin, we found that PEG-400/oleic acid (80/20%) achieved the highest efficiency, reducing the optical attenuation coefficient (OAC) by 23.8% ± 1.7% within 15 min. Fructose-based and aqueous tartrazine formulations also showed significant reductions (16.8% and 20.4%). Conversely, our results show that MC does not effectively reduce skin optical attenuation. These findings demonstrate that OCAs provide a more potent, stable reduction in OAC, offering a superior strategy for optimizing light delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.